B. Paudel
PhD Candidate
Last active: 10/9/2019

Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition.

Hardeman KN, Peng C, Paudel BB, Meyer CT, Luong T, Tyson DR, Young JD, Quaranta V, Fessel JP
Sci Rep. 2017 7: 42604

PMID: 28205616 · PMCID: PMC5311997 · DOI:10.1038/srep42604

MeSH Terms (17)

Antineoplastic Agents Cell Line, Tumor Drug Resistance, Neoplasm Glucose Glycolysis Humans Indoles Melanoma Molecular Targeted Therapy Mutation Oncogenes Pharmacogenomic Variants Phenotype Protein Kinase Inhibitors Proto-Oncogene Proteins B-raf Sulfonamides Treatment Outcome

Connections (5)

This publication is referenced by other Labnodes entities:

Links